Updates are available Correction dated 2018-10-24
Click to view Correction: https://doi.org/10.1186/s13741-018-0106-7
-
Authors
,
Morkane, Clare M.
McKenna, Helen
Cumpstey, Andrew F.
Oldman, Alex H.
Grocott, Michael P. W.
Martin, Daniel S.
-
Funding
Funding for this research was provided by:
National Institute for Health Research (Academic Clinical Fellowship (ACF))
- License Information
-
More Information
Article History
Received: 4 May 2018
Accepted: 6 July 2018
First Online: 24 July 2018
Change Date: 24 October 2018
Change Type: Correction
Change Details: Following publication of the original article (Morkane et al., 2018), it was noticed that the second collaborating group ‘South Coast Perioperative Audit and Research Collaboration (SPARC)’ was not displayed on the HTML online version due to an error by the Publisher.
Ethics approval and consent to participate
: Research and development departments at both the Royal Free Hospital and University Hospital Southampton reviewed the study separately and agreed that as the study was a service evaluation, research ethics approval was not required. Local governance approval was obtained at every participating centre.
: Not applicable.
: Professor Michael P. W. Grocott (MPWG) serves on the medical advisory board of Sphere Medical Ltd. and is a director of Oxygen Control Systems Ltd. He has received honoraria for speaking for and/or travel expenses from BOC Medical (Linde Group), Edwards Lifesciences and Cortex GmBH. MPWG leads the Xtreme Everest Oxygen Research Consortium and the Fit-4-Surgery research collaboration. Some of this work was undertaken at University Southampton NHS Foundation Trust–University of Southampton NIHR Biomedical Research Centre. MPWG serves as the UK NIHR CRN national specialty group lead for Anaesthesia Perioperative Medicine and Pain and is an elected council member of the Royal College of Anaesthetists, an elected board member of the Faculty of Intensive Care Medicine and president of the Critical Care Medicine Section of the Royal Society of Medicine.Daniel Martin has received consultancy fees from Siemens Healthcare and Masimo and lecture honoraria from Edwards Lifesciences and Deltex Medical. He is also a Director of Oxygen Control Ltd.Dr. Andrew Cumpstey is currently funded through the NIHR as an Academic Clinical Fellow. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
